Structural properties of the ectodomain of hepatitis C virus E2 envelope protein (Q42983297)

12 November 2017

Structural properties of the ectodomain of hepatitis C virus E2 envelope protein (English)

1 reference

12 November 2017

1 reference

3

1 reference

12 November 2017

9

1 reference

12 November 2017

Julián Gómez-Gutiérrez

object named as

Julián Gómez-Gutiérrez

4

0 references

Beatriz Pacheco

object named as

Beatriz Pacheco

5

0 references

author name string

Mar Rodríguez-Rodríguez

1

1 reference

12 November 2017

Daniel Tello

2

1 reference

12 November 2017

Sara Ortega

6

1 reference

12 November 2017

Alicia G Serrano

7

1 reference

12 November 2017

Darrell L Peterson

8

1 reference

12 November 2017

6 December 2008

1 reference

12 November 2017

1 reference

12 November 2017

139

1 reference

12 November 2017

1

1 reference

12 November 2017

91-99

1 reference

Cell entry of hepatitis C virus

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Glycosylation of hepatitis C virus envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Intracellular functions of N-linked glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Hypervariable regions in the putative glycoprotein of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Marked sequence diversity in the putative envelope proteins of hepatitis C viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Solute perturbation of protein fluorescence. Quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Characterization of truncated forms of hepatitis C virus glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Biogenesis of hepatitis C virus envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Convex constraint analysis: a natural deconvolution of circular dichroism curves of proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

A model for the hepatitis C virus envelope glycoprotein E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Characterisation of bacterially expressed structural protein E2 of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.10.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2008.10.013

1 reference

12 November 2017

1 reference